Hepatic fat quantification using the two‐point Dixon method and fat color maps based on non‐alcoholic fatty liver disease activity score. Issue 5 (31st July 2016)

• Record Type: Journal Article
• Authors: Hayashi, Tatsuya; Saitoh, Satoshi; Takahashi, Junji; Tsuji, Yoshinori; Ikeda, Kenji; Kobayashi, Masahiro; Kawamura, Yusuke; Fujii, Takeshi; Inoue, Masafumi; Miyati, Tosiaki; Kumada, Hiromitsu
• Is Part Of: Hepatology research. Volume 47:Issue 5(2017)
• Page Start: 455
• Page End: 464
• Publication Date: 2016-07-31
• Subjects: fatty liver -- magnetic resonance imaging -- non‐alcoholic fatty liver disease -- non‐alcoholic steatohepatitis; Liver -- Diseases -- Periodicals; Liver Diseases -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1111/hepr.12767
• Languages: English
• ISSNs: 1386-6346

Abstract

Abstract: Aim: The two‐point Dixon method for magnetic resonance imaging (MRI) is commonly used to non‐invasively measure fat deposition in the liver. The aim of the present study was to assess the usefulness of MRI‐fat fraction (MRI‐FF) using the two‐point Dixon method based on the non‐alcoholic fatty liver disease activity score. Methods: This retrospective study included 106 patients who underwent liver MRI and MR spectroscopy, and 201 patients who underwent liver MRI and histological assessment. The relationship between MRI‐FF and MR spectroscopy‐fat fraction was used to estimate the corrected MRI‐FF for hepatic multi‐peaks of fat. Then, a color FF map was generated with the corrected MRI‐FF based on the non‐alcoholic fatty liver disease activity score. We defined FF variability as the standard deviation of FF in regions of interest. Uniformity of hepatic fat was visually graded on a three‐point scale using both gray‐scale and color FF maps. Confounding effects of histology (iron, inflammation and fibrosis) on corrected MRI‐FF were assessed by multiple linear regression. Results: The linear correlations between MRI‐FF and MR spectroscopy‐fat fraction, and between corrected MRI‐FF and histological steatosis were strong ( R 2 = 0.90 and R 2 = 0.88, respectively). Liver fat variability significantly increased with visual fat uniformity grade using both of the maps (ρ = 0.67–0.69, both P < 0.001). Hepatic iron, inflammation and fibrosis had no significant confounding effects on the corrected MRI‐FF (all P > 0.05). Conclusions: The two‐point Dixon method and the gray‐scale or color FF maps based on the non‐alcoholic fatty liver disease activity score were useful for fat quantification in the liver of patients without severe iron deposition.